Our top pick for
Teleflex Incorporated is a medical instruments & supplies business based in the US. Teleflex Incorporated shares (TFX) are listed on the NYSE and all prices are listed in US Dollars. Teleflex Incorporated employs 14,000 staff and has a trailing 12-month revenue of around USD$2.5 billion.
|52-week range||USD$220.6438 - USD$414.72|
|50-day moving average||USD$393.3982|
|200-day moving average||USD$375.8325|
|Wall St. target price||USD$455.09|
|Dividend yield||USD$1.36 (0.34%)|
|Earnings per share (TTM)||USD$7.09|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Teleflex Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Teleflex Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Teleflex Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 57x. In other words, Teleflex Incorporated shares trade at around 57x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Teleflex Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.2268. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Teleflex Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Teleflex Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$657.2 million.
The EBITDA is a measure of a Teleflex Incorporated's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$2.5 billion|
|Operating margin TTM||16.95%|
|Gross profit TTM||USD$1.3 billion|
|Return on assets TTM||3.99%|
|Return on equity TTM||10.63%|
|Market capitalisation||USD$18.9 billion|
TTM: trailing 12 months
There are currently 524,386 Teleflex Incorporated shares held short by investors – that's known as Teleflex Incorporated's "short interest". This figure is 16.6% down from 628,800 last month.
There are a few different ways that this level of interest in shorting Teleflex Incorporated shares can be evaluated.
Teleflex Incorporated's "short interest ratio" (SIR) is the quantity of Teleflex Incorporated shares currently shorted divided by the average quantity of Teleflex Incorporated shares traded daily (recently around 192082.78388278). Teleflex Incorporated's SIR currently stands at 2.73. In other words for every 100,000 Teleflex Incorporated shares traded daily on the market, roughly 2730 shares are currently held short.
However Teleflex Incorporated's short interest can also be evaluated against the total number of Teleflex Incorporated shares, or, against the total number of tradable Teleflex Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Teleflex Incorporated's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Teleflex Incorporated shares in existence, roughly 10 shares are currently held short) or 0.0146% of the tradable shares (for every 100,000 tradable Teleflex Incorporated shares, roughly 15 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Teleflex Incorporated.
Find out more about how you can short Teleflex Incorporated stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Teleflex Incorporated.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 35.61
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Teleflex Incorporated's overall score of 35.61 (as at 01/01/2019) is nothing to write home about – landing it in it in the 58th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Teleflex Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 9.64/100
Teleflex Incorporated's environmental score of 9.64 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Teleflex Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 20.95/100
Teleflex Incorporated's social score of 20.95 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Teleflex Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 13.53/100
Teleflex Incorporated's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Teleflex Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Teleflex Incorporated scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Teleflex Incorporated has, for the most part, managed to keep its nose clean.
|Total ESG score||35.61|
|Total ESG percentile||58.08|
|Environmental score percentile||7|
|Social score percentile||7|
|Governance score percentile||7|
|Level of controversy||2|
Dividend payout ratio: 12.75% of net profits
Recently Teleflex Incorporated has paid out, on average, around 12.75% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.34% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Teleflex Incorporated shareholders could enjoy a 0.34% return on their shares, in the form of dividend payments. In Teleflex Incorporated's case, that would currently equate to about $1.36 per share.
While Teleflex Incorporated's payout ratio might seem low, this can signify that Teleflex Incorporated is investing more in its future growth.
Teleflex Incorporated's most recent dividend payout was on 15 December 2020. The latest dividend was paid out to all shareholders who bought their shares by 4 March 2021 (the "ex-dividend date").
Teleflex Incorporated's shares were split on a 2:1 basis on 17 June 1997. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Teleflex Incorporated shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Teleflex Incorporated shares which in turn could have impacted Teleflex Incorporated's share price.
Over the last 12 months, Teleflex Incorporated's shares have ranged in value from as little as $220.6438 up to $414.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Teleflex Incorporated's is 1.2054. This would suggest that Teleflex Incorporated's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products consist of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management for patients in the hospital and individuals in the home care markets. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.